Nephros (NEPH) Shares Outstanding (Diluted Average) (2010 - 2026)

Nephros has reported Shares Outstanding (Diluted Average) for 10 years, with the latest figure at $11.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 3.53% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $11.0 million (up 3.53% YoY), and the FY2025 full-year result was $11.0 million, up 3.45% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $11.0 million, roughly flat from $11.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $11.0 million in Q3 2025, with the low at $10.3 million in Q2 2022.
• Average Shares Outstanding (Diluted Average) over 5 years is $10.6 million, with a median of $10.5 million recorded in 2024.
• Year-over-year, Shares Outstanding (Diluted Average) advanced 0.31% in 2023 and advanced 4.96% in 2025.
• Tracing NEPH's Shares Outstanding (Diluted Average) over 5 years: stood at $10.3 million in 2022, then increased by 0.86% to $10.4 million in 2023, then climbed by 2.08% to $10.6 million in 2024, then rose by 3.45% to $11.0 million in 2025, then rose by 0.21% to $11.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $11.0 million (Q1 2026), $11.0 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.

Peer Comparison